Latest stock market podcasts

Between the BellsThe Bellcast
Between the Bells

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pancreatic cancer, and its substantial market opportunities in the US.

Morning Bell 7 April

Bell Direct
April 7, 2020

Morning Bell 6 April

Bell Direct
April 6, 2020

Weekly Wrap 3 April

Bell Direct
April 3, 2020

Market Update 2 April

Bell Direct
April 2, 2020

Market Update 1 April

Bell Direct
April 1, 2020

March Market Overview

Bell Direct
March 31, 2020

Market Update 31 March

Bell Direct
March 31, 2020

Weekly Wrap 27 March

Bell Direct
March 27, 2020

Morning Bell 24 March

Bell Direct
March 24, 2020

Morning Bell 23 March

Bell Direct
March 23, 2020

Market Update 20 March

Bell Direct
March 20, 2020

From the Helm: Bubs Australia founder & CEO Kristy Carr, on the global market

Bell Direct
March 19, 2020
  1. Pages:
  3. 1
  4. ...
  5. 140
  6. 141
  7. 142
  8. 143
  9. 144
  10. 145
  11. 146
  12. 147